Kintayl Capital’s Avidity Biosciences RNAM Stock Holding History

Kintayl Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,437	Closed	-$1.62M	–	70
2025 Q4	$1.62M	Buy	+22,437	New	+$1.45M	0.98%	31

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Kintayl Capital's RNAM Position: Q1 2026 in Review

Kintayl Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 22,437 shares — an estimated $1.62M sold.

Kintayl Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.62M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Kintayl Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Kintayl Capital sold 22,437 Avidity Biosciences shares in Q1 2026, an estimated $1.62M.
Kintayl Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Kintayl Capital's Avidity Biosciences position peaked at $1.62M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Kintayl Capital's 13F filing for Q1 2026, filed 15 May 2026.